AGILENT TECHNOLOGIES INC AGILEN (0HAV.L) Financials
0HAV.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-01-31 | 10.9 billion | 4.8 billion |
| 2023-10-31 | 10.8 billion | 4.9 billion |
| 2023-07-31 | 10.7 billion | 5.1 billion |
| 2023-04-30 | 10.8 billion | 5.0 billion |
0HAV.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-01-31 | 395.0 million | ? |
| 2023-10-31 | 432.0 million | 13.0 million |
| 2023-07-31 | 481.0 million | 29.0 million |
| 2023-04-30 | 341.0 million | 25.0 million |
0HAV.L Net Income
| Date | Net Income |
|---|---|
| 2024-01-31 | 348.0 million |
| 2023-10-31 | 475.0 million |
| 2023-07-31 | 111.0 million |
| 2023-04-30 | 302.0 million |
0HAV.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-01-31 | 1.7 billion | - | - |
| 2023-10-31 | 1.6 billion | - | - |
| 2023-07-31 | 1.3 billion | - | - |
| 2023-04-30 | 1.2 billion | - | - |
0HAV.L Shares Outstanding
0HAV.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-01-31 | 90.0 million | 120.0 million | - | - |
| 2023-10-31 | 84.0 million | 114.0 million | - | - |
| 2023-07-31 | 81.0 million | 118.0 million | - | - |
| 2023-04-30 | 57.0 million | 126.0 million | - | - |
0HAV.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-01-31 | 1.7 billion | 745.0 million |
| 2023-10-31 | 1.7 billion | 762.0 million |
| 2023-07-31 | 1.7 billion | 765.0 million |
| 2023-04-30 | 1.7 billion | 790.0 million |
0HAV.L
Price: $154.74
Dividend Yield: 0.01%
Forward Dividend Yield: 0.61%
Payout Ratio: 22.77%
Dividend Per Share: 0.94 USD
Earnings Per Share: 4.15 USD
P/E Ratio: 33.43
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 444.7 million
Average Dividend Frequency: 4
Years Paying Dividends: 7
DGR3: 7.17%
DGR5: 7.60%